Study guide
5.3 Epidemiological Study Designs and Measures of Association
CIH Certified Industrial Hygienist Exam
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: The CIH Exam and How to Use This Guide
1.1 CIH Exam Format, Scoring, and Test-Day Logistics 1.2 Eligibility, Application Windows, Fees, and Certification Maintenance 1.3 The BGC Blueprint, Subject Areas, and a Calculation-First Study Plan
2 Chapter 2: Basic Science & Calculations
2.1 Gas Laws and Vapor Calculations 2.2 Unit Conversions: ppm, mg/m³, and Standard Temperature/Pressure 2.3 Fluid Mechanics and Airflow Fundamentals
3 Chapter 3: Air Sampling & Instrumentation
3.1 Active and Passive Air Sampling Strategies 3.2 Particulate and Aerosol Sampling 3.3 Direct-Reading Instruments and Calibration
4 Chapter 4: Analytical Chemistry & Lab Methods
4.1 Gas Chromatography and Mass Spectrometry 4.2 High-Performance Liquid Chromatography and Ion Chromatography 4.3 Spectroscopy and Elemental Analysis 4.4 Gravimetric, Microscopy, and Wet Chemical Methods 4.5 Laboratory Quality Assurance, Chain of Custody, and Desorption Efficiency
5 Chapter 5: Biostatistics & Epidemiology
5.1 Lognormal Distributions and Exposure Data Statistics 5.2 Upper Confidence Limits (UCL95) and Compliance Decision Rules 5.3 Epidemiological Study Designs and Measures of Association 5.4 Sampling Strategy: Sample Size, Power, and Worker Selection
6 Chapter 6: Toxicology & Biological Monitoring
6.1 Dose-Response Relationships and Points of Departure 6.2 Toxicokinetics: Absorption, Distribution, Metabolism, and Elimination 6.3 Aerosol Deposition, Clearance, and Respiratory Tract Dosimetry 6.4 Hepatic, Renal, Neurologic, and Hematologic Target Organ Toxicity 6.5 Pulmonary Toxicology, Carcinogenicity, and Reproductive Hazards 6.6 OEL Frameworks, Classifications, and Excursion Limits 6.7 Chemical Mixtures and Extended Work-Shift OEL Adjustments 6.8 Biological Exposure Indices (BEIs) and Biomonitoring
7 Chapter 7: Biohazards & Indoor Environmental Quality
7.1 Mold, Fungi, and Microbial Contaminants 7.2 Infectious Agents, Bloodborne Pathogens, and Biosafety Levels 7.3 Indoor Environmental Quality (IEQ) Investigations 7.4 Sanitation, Potable Water, and Personal Hygiene Programs
8 Chapter 8: Community Exposure & Environmental Health
8.1 Clean Air Act Framework, NAAQS, and New Source Review 8.2 Hazardous Air Pollutants, CEMS, and EPA Reference Methods 8.3 Atmospheric Stability, Lapse Rates, and Plume Morphology 8.4 Gaussian Plume Modeling, Plume Rise, and Environmental Fate 8.5 HAZWOPER Scope, Mandates, and Training Tiers 8.6 Protection Levels, Site Zoning, Incident Command, and Decontamination 8.7 Water Pollution, Hazardous Waste, and Community Right-to-Know
9 Chapter 9: Health Risk Analysis & Hazard Communication
9.1 GHS Hazard Classification: Health and Physical Hazard Criteria 9.2 GHS Labels, Safety Data Sheets, and Trade Secret Rules 9.3 The AIHA Exposure Assessment Strategy and Similar Exposure Groups 9.4 Qualitative Exposure Profiling and the AIHA Risk Matrix 9.5 Quantitative Health Risk Characterization: HQ, HI, and ELCR 9.6 NIOSH Occupational Exposure Banding 9.7 Risk Communication and Reporting to Affected Parties
10 Chapter 10: Industrial Ventilation Principles & LEV Design
10.1 Elimination, Substitution, Isolation, Containment, and Process Change 10.2 LEV Hood Taxonomy and Capture Velocity Selection 10.3 Hood Airflow Equations, Entry Losses, and Hood Static Pressure 10.4 Particulate Transport Aerodynamics and Duct Sizing 10.5 Duct Friction, Fitting Losses, and System Balancing 10.6 Fan Categories and Pressure Dynamics Across the Fan 10.7 System Curves, the Fan Laws, and Density Corrections
11 Chapter 11: General Ventilation, Air Cleaning & Diagnostics
11.1 Dilution Ventilation Principles and Steady-State Modeling 11.2 Transient Purging and Air Distribution Geometry 11.3 Particulate Air Cleaning: Cyclones, Baghouses, Scrubbers, and ESPs 11.4 Gaseous Emission Control and Air Cleaner Selection 11.5 Ventilation System Troubleshooting and Testing
12 Chapter 12: Noise Measurement & Hearing Conservation
12.1 Acoustic Physics and Decibel Mathematics 12.2 Sound Propagation, Octave Bands, and Frequency Weighting 12.3 Noise Dose Metrics and OSHA versus ACGIH Criteria 12.4 Exchange Rates, Extended Shifts, and Dosimetry Field Protocols 12.5 Engineering Noise Controls and Hearing Protector Attenuation 12.6 Hearing Conservation Programs and Standard Threshold Shifts 12.7 Hand-Arm and Whole-Body Vibration
13 Chapter 13: Thermal Stress Assessment & Control
13.1 Wet Bulb Globe Temperature (WBGT) and Heat Stress Indices 13.2 Heat-Related Disorders, Acclimatization, and Work/Rest Regimens 13.3 Cold Stress Evaluation and Wind Chill
14 Chapter 14: Ionizing Radiation Protection
14.1 Ionizing Radiation Physics and Radioactive Decay Kinetics 14.2 Radiation Units, Radiobiology, and Health Effects 14.3 ALARA, Stay-Time, and the Inverse Square Law 14.4 Shielding Physics, Material Selection, and Gamma Constants 14.5 Radiation Detection Instruments and Spectrometry 14.6 Personnel Dosimetry, Dose Limits, and Contamination Surveys
15 Chapter 15: Non-Ionizing Radiation & Laser Safety
15.1 The Non-Ionizing Spectrum and Static/ELF Field Exposures 15.2 Radiofrequency and Microwave Exposure: SAR, Standards, and Surveys 15.3 Ultraviolet, Visible, and Infrared Radiation Hazards 15.4 Laser Safety Classifications and Optical Density Calculations 15.5 Illumination, Lighting Design, and Visual Performance
16 Chapter 16: Non-Engineering Controls & Personal Protective Equipment
16.1 Respiratory Protection Programs and Assigned Protection Factors 16.2 Maximum Use Concentration, Oxygen Deficiency, and Breathing Air 16.3 Particulate Filters, Sorbent Cartridges, and Change Schedules 16.4 Respirator Fit Testing Protocols 16.5 Chemical Protective Clothing and Dermal Exposure Control
17 Chapter 17: Ergonomics & Workstation Design
17.1 Soft-Tissue Biomechanics and WMSD Pathophysiology 17.2 Ergonomic Risk Factors and Their Interaction Effects 17.3 The Revised NIOSH Lifting Equation 17.4 RULA, REBA, the Strain Index, and the ACGIH HAL TLV 17.5 Anthropometry and Workstation Geometry 17.6 VDT Workstations, Hand Tool Design, and Administrative Ergonomics
18 Chapter 18: Work Environments & Industrial Processes
18.1 Welding Fume Emissions, Metal Fume Fever, and Cr(VI)/Manganese Toxicology 18.2 Foundry Operations and Hot Work Fire Prevention 18.3 Vapor Degreasing, Pickling, Electroplating, and Cyanide Baths 18.4 Spray Coatings, Isocyanates, and Semiconductor Manufacturing 18.5 Confined Spaces and High-Hazard Industrial Operations 18.6 Asbestos, Lead, and Silica: Regulated Substance Programs 18.7 Abrasive Blasting and Surface Preparation
19 Chapter 19: IH Program Management & Professional Ethics
19.1 The BGC Code of Ethics: Canons and Enforcement 19.2 Professional Liability, Standard of Care, and Expert Testimony 19.3 Occupational Health & Safety Management Systems (ISO 45001, ANSI Z10) 19.4 Exposure Records Access and Medical Surveillance 19.5 OSHA Injury and Illness Recordkeeping and Enforcement
5.3 Epidemiological Study Designs and Measures of Association
Key Takeaways Explain This Topic AI
Cohort studies track exposed and unexposed populations over time to calculate true disease incidence and Relative Risk (RR = [a/(a+b)] / [c/(c+d)]), providing the strongest observational evidence for occupational etiology.
Case-Control studies select subjects based on disease status and ascertain past exposure history to calculate the Odds Ratio (OR = (a·d) / (b·c)), which closely approximates Relative Risk under the rare disease assumption.
The Standardized Mortality Ratio (SMR = (Observed Deaths / Expected Deaths) · 100) compares cohort mortality to general population rates, where values < 100 often reflect the Healthy Worker Effect.
Confounding occurs when a third variable is independently associated with both exposure and outcome without being an intermediate causal step; effect modification represents a true biological interaction across strata.
Sir Austin Bradford Hill's nine criteria evaluate causal association, with Temporality (exposure preceding disease) representing the only absolute, non-negotiable prerequisite.
Last updated: August 2026
Epidemiological Study Designs and Measures of Association
Occupational epidemiology is the study of the distribution and determinants of disease, injury, and mortality in working populations. While industrial hygiene focuses on identifying, evaluating, and controlling workplace hazards, occupational epidemiology provides the empirical human evidence used to establish Occupational Exposure Limits (OELs) , validate toxicological dose-response models, and substantiate causal relationships between workplace exposures and chronic occupational illnesses.
1. Fundamental Epidemiological Study Designs
Epidemiological studies are categorized into experimental designs (e.g., randomized controlled trials, rarely ethical in occupational exposure settings) and observational designs , which observe workers in their natural employment environments. EPIDEMIOLOGICAL STUDY DESIGNS IN OCCUPATIONAL HEALTH
- │
- ├── Cohort Studies (Exposed vs. Unexposed → Followed over Time → Disease Incidence)
- │ ├── Prospective (Concurrent) Cohort: Followed forward from present into future
- │ └── Retrospective (Historical) Cohort: Reconstructed backward using employment records
- │
- ├── Case-Control Studies (Diseased [Cases] vs. Non-Diseased [Controls] → Past Exposure History)
- │
- └── Cross-Sectional Studies (Snapshot in Time → Simultaneous Exposure & Disease Prevalence)
- Comparison of Major Observational Study Designs
Feature Cohort Study Case-Control Study Cross-Sectional Study
Study Population Selection Based on Exposure Status (Exposed vs. Unexposed) Based on Disease Status (Cases vs. Controls) Single population sample assessed at one point in time
Temporal Direction Forward in time (Exposure → Disease outcome) Backward in time (Disease → Past exposure history) Simultaneous (Exposure and Disease measured at same instant)
Primary Measure of Association Relative Risk (RR) & Rate Ratio Odds Ratio (OR) Prevalence Ratio (PR) & Prevalence Odds Ratio
Can Directly Measure Incidence? Yes (Cumulative incidence & incidence density) No (Incidence cannot be determined) No (Measures prevalence, not incidence)
Best Suited For Rare exposures; multiple disease outcomes; high-exposure cohorts Rare diseases (e.g., angiosarcoma, mesothelioma); long-latency diseases Common chronic conditions with slow onset (e.g., hearing loss, dermatitis)
Key Strengths Establishes clear temporal sequence; minimizes recall bias Fast; inexpensive; requires small sample sizes; evaluates multiple exposures Inexpensive; rapid; excellent for initial hypothesis generation
Key Vulnerabilities Expensive; attrition (loss to follow-up); Healthy Worker Effect Highly vulnerable to Recall Bias and control selection bias Cannot establish temporality ("chicken-or-egg" dilemma); survivor bias
2. Measures of Association: Mathematical Formulations
Epidemiological measures of association quantify the strength of the statistical relationship between an occupational exposure and a health outcome. All calculations derive from the standard 2 × 2 contingency table.
The Standard 2 × 2 Contingency Table
- Exposure Status Disease Present (D+) Disease Absent (D-) Total Cohort Population
- Exposed (E+) a (Exposed Cases) b (Exposed Non-Cases) a + b (Total Exposed)
- Unexposed (E-) c (Unexposed Cases) d (Unexposed Non-Cases) c + d (Total Unexposed)
- Total Population a + c (Total Cases) b + d (Total Non-Cases) n = a + b + c + d
- Relative Risk (Risk Ratio, RR)
Used strictly in cohort studies , the Relative Risk (RR) is the ratio of the cumulative disease incidence in the exposed group (Ie) to the cumulative disease incidence in the unexposed group (Iu): I e = a a + b , I u = c c + d I_e = \frac{a}{a + b}, \qquad I_u = \frac{c}{c + d} I e = a + b a , I u = c + d c R R = I e I u = a a + b c c + d = a ⋅ ( c + d ) c ⋅ ( a + b ) \mathbf{RR = \frac{I_e}{I_u} = \frac{\frac{a}{a + b}}{\frac{c}{c + d}} = \frac{a \cdot (c + d)}{c \cdot (a + b)}} RR = I u I e = c + d c a + b a = c ⋅ ( a + b ) a ⋅ ( c + d )
Interpretation:
RR = 1.0: No association between exposure and disease.
RR > 1.0: Positive association (exposure increases disease risk; e.g., RR = 2.5 indicates exposed workers have 2.5 times the risk of unexposed workers).
RR < 1.0: Negative/protective association (exposure reduces disease risk).
Attributable Risk (AR) & Attributable Fraction (AR%)
Attributable Risk (Risk Difference, AR): The excess disease incidence directly attributable to the occupational exposure: A R = I e − I u = a a + b − c c + d \mathbf{AR = I_e - I_u = \frac{a}{a + b} - \frac{c}{c + d}} AR = I e − I u = a + b a − c + d c
Attributable Risk Percent (Etiologic Fraction in Exposed, AR%): The proportion of disease cases among the exposed that would be eliminated if the occupational exposure were completely removed: A R % = ( I e − I u I e ) × 100 % = ( R R − 1 R R ) × 100 % \mathbf{AR\% = \left( \frac{I_e - I_u}{I_e} \right) \times 100\% = \left( \frac{RR - 1}{RR} \right) \times 100\%} AR% = ( I e I e − I u ) × 100% = ( RR RR − 1 ) × 100%
Odds Ratio (OR)
In case-control studies , total population counts (a+b and c+d) are unknown because the investigator chooses the number of cases and controls. Therefore, true incidence cannot be computed. Instead, the Odds Ratio (OR) is calculated: Odds of exposure in Cases = a c , Odds of exposure in Controls = b d \text{Odds of exposure in Cases} = \frac{a}{c}, \qquad \text{Odds of exposure in Controls} = \frac{b}{d} Odds of exposure in Cases = c a , Odds of exposure in Controls = d b O R = a / c b / d = a ⋅ d b ⋅ c \mathbf{OR = \frac{a / c}{b / d} = \frac{a \cdot d}{b \cdot c}} OR = b/d a/c = b ⋅ c a ⋅ d
The Rare Disease Assumption
When the disease under investigation is biologically rare in both exposed and unexposed populations (a << b and c << d, such that a + b ≈ b and c + d ≈ d), the Odds Ratio mathematically converges to the Relative Risk: R R = a / ( a + b ) c / ( c + d ) ≈ a / b c / d = a ⋅ d b ⋅ c = O R RR = \frac{a / (a + b)}{c / (c + d)} \approx \frac{a / b}{c / d} = \frac{a \cdot d}{b \cdot c} = OR RR = c / ( c + d ) a / ( a + b ) ≈ c / d a / b = b ⋅ c a ⋅ d = OR
Rule for the CIH Exam: If a disease has a cumulative incidence of less than ≈ 5% to 10% in the study population, the Odds Ratio (OR) derived from a case-control study is a valid mathematical surrogate for the Relative Risk (RR).
3. Standardized Mortality Ratio (SMR) and Indirect Standardization
In occupational cohort studies, researchers frequently compare the observed mortality experience of an industrial workforce against the mortality rates of the general population (e.g., national or state vital statistics).
Because the general population includes infants, the elderly, and disabled individuals, simple crude mortality comparisons are invalid. Indirect standardization adjusts for demographic differences in age, sex, race, and calendar time.
Calculating the Standardized Mortality Ratio (SMR) S M R = ( Observed Number of Deaths ( O ) Expected Number of Deaths ( E ) ) × 100 \mathbf{SMR = \left( \frac{\text{Observed Number of Deaths } (O)}{\text{Expected Number of Deaths } (E)} \right) \times 100} SMR = ( Expected Number of Deaths ( E ) Observed Number of Deaths ( O ) ) × 100
Where the Expected Number of Deaths (E) is calculated by summing across age- and calendar-strata: E = ∑ i = 1 k ( Person-Years of Follow-Up in Stratum i ) × ( Standard Mortality Rate in Stratum i ) E = \sum_{i=1}^{k} \left( \text{Person-Years of Follow-Up in Stratum } i \right) \times \left( \text{Standard Mortality Rate in Stratum } i \right) E = i = 1 ∑ k ( Person-Years of Follow-Up in Stratum i ) × ( Standard Mortality Rate in Stratum i )
Interpretation of SMR:
SMR = 100: Observed cohort mortality matches general population expectation.
SMR > 100: Excess mortality in the cohort (e.g., SMR = 165 indicates a 65% excess mortality risk above general population baseline).
SMR < 100: Cohort experienced lower mortality than the general population.
(Note: When evaluating disease incidence rather than mortality, the exact same mathematical formulation is called the Standardized Incidence Ratio, SIR ).
4. Threats to Study Validity: Confounding vs. Effect Modification
Epidemiological investigations must distinguish between artifactual statistical distortions and genuine biological phenomena. CONFOUNDING TRIANGLE
- Confounder (Z)
- / \
- / (Associated) \ (Independent Risk Factor)
- v v
- Exposure (E) --------> Disease (D)
- (True Causal Path?)
- Confounding Variables
Confounding is a mixing of effects where the apparent association between an occupational exposure (E) and a disease (D) is distorted by an extraneous third variable (Z).
Three Strict Criteria for a Variable to Be a Confounder:
It must be an independent risk factor for the disease outcome among unexposed individuals.
It must be statistically associated with the exposure in the study population.
It must NOT be an intermediate step on the causal biological pathway between exposure and disease (E → Z → D).
Classic Occupational Example: In an epidemiological study evaluating lung cancer risk among asbestos-exposed insulators, cigarette smoking is a major confounder. Smoking is an independent cause of lung cancer and may be correlated with employment history, distorting the crude risk estimate if not controlled.
Methods to Control Confounding:
In Study Design: Restriction (e.g., studying only non-smokers), Matching (matching cases and controls on age/smoking status).
In Data Analysis: Stratification (Cochran-Mantel-Haenszel pooling across strata), Multivariable Regression (multiple logistic regression, Cox proportional hazards modeling).
Effect Modification (Interaction)
Effect Modification (Interaction) is a real biological phenomenon where the magnitude of the exposure-disease association differs across strata of a third variable.
Confounding vs. Effect Modification: Confounding is a bias that the researcher must eliminate or adjust for. Effect modification is a biological reality that must be reported and described.
Classic Occupational Example: The synergistic, supra-multiplicative interaction between asbestos exposure and cigarette smoking on bronchogenic lung cancer:
- Baseline unexposed non-smokers: RR = 1.0
- Asbestos exposure alone (non-smokers): RR ≈ 5.0
- Cigarette smoking alone (unexposed to asbestos): RR ≈ 10.0
Combined asbestos exposure AND cigarette smoking: RR ≈ 50.0 (multiplicative synergistic effect, not merely additive 5 + 10 = 15).
5. Systematic Biases in Occupational Epidemiology
Bias is any systematic error in the design, conduct, or analysis of a study that results in an erroneous estimate of the exposure-disease association.
1. The Healthy Worker Effect (HWE)
The Healthy Worker Effect is the single most pervasive selection bias in occupational health studies.
Mechanism: To enter and maintain active employment, individuals must be relatively healthy. The general population—used as the comparison group in SMR calculations—contains chronically ill, severely disabled, institutionalized, and unemployed individuals with high baseline mortality rates.
Impact: Overall all-cause mortality in an active workforce is typically 70% - 90% of the general population (SMR = 70 - 90) .
Consequence: The HWE can mask true occupational hazards. An observed all-cause SMR = 100 in a working cohort does not indicate safety—it often conceals an underlying excess occupational mortality that is counterbalanced by the workforce's baseline health advantage.
Mitigation: Compare the exposed worker cohort against an internal unexposed or low-exposure occupational control group (e.g., administrative plant workers) rather than the general population.
2. Information and Observation Biases
Recall Bias: Differential recollection of past chemical exposures between diseased cases and healthy controls in retrospective case-control studies. Parents of children with birth defects or workers diagnosed with leukemia scrutinize their past chemical exposures far more intensely than healthy controls, artificially inflating the calculated Odds Ratio.
Interviewer / Observer Bias: Systematic error introduced when the interviewer knows the subject's disease or exposure status and probes more aggressively.
Misclassification Bias:
Non-Differential Misclassification: Exposure or disease measurement errors occur equally across all groups (random error). Always biases the measure of association toward the null (RR → 1.0, OR → 1.0) , diluting true causal signals.
Differential Misclassification: Measurement errors differ systematically between groups. Biases the effect estimate unpredictably (either toward or away from the null).
6. The Bradford Hill Criteria for Causal Inference
In 1965, Sir Austin Bradford Hill articulated nine classic criteria to help scientists determine whether an observed statistical association reflects true biological causality :
Criterion Scientific Definition & Occupational Hygiene Application
1. Temporality The exposure must precede the development of the disease. (The only absolute, non-negotiable criterion). Crucial for chronic diseases with long latency periods (e.g., 20–40 years between asbestos exposure and malignant mesothelioma).
2. Strength of Association Strong associations (high RR or OR, such as RR > 5.0) are more likely to be causal because minor uncontrolled confounding is unlikely to account for the entire effect (e.g., RR ≈ 200 for vinyl chloride and hepatic angiosarcoma).
3. Biological Gradient (Dose-Response) Risk or severity of disease increases monotonically with increasing intensity, duration, or cumulative exposure (e.g., cumulative silica dust-years vs. silicosis incidence).
4. Biological Plausibility The observed epidemiological relationship is consistent with known physiological, toxicological, and cellular mechanisms (e.g., benzene metabolites causing hematopoietic stem cell mutation).
5. Consistency The association is repeatedly observed across independent studies conducted by different researchers, in different geographic regions, using diverse study designs.
6. Coherence The causal interpretation does not conflict with the known natural history, pathology, and biology of the disease.
7. Specificity A single specific exposure leads to a distinct, unique disease outcome (e.g., bis(chloromethyl)ether and oat-cell lung carcinoma). Note: Absence of specificity does NOT disprove causality, as agents like tobacco smoke cause multiple diverse cancers.
8. Experiment (Reversibility) Reducing, controlling, or eliminating the occupational exposure leads to a measurable decrease in disease incidence or symptoms (e.g., resolution of occupational asthma symptoms during vacation periods).
9. Analogy Structural or toxicological similarity exists with known causal agents (e.g., observing toxicity from a newly synthesized chlorinated solvent by analogy to carbon tetrachloride).
- 7. Worked Step-by-Step Calculation Examples
- Worked Example 4.3.1: Relative Risk & Attributable Risk in a Cohort Study
Problem: An occupational health department tracks a cohort of 1,000 cadmium-exposed electroplating workers and an unexposed comparison cohort of 2,000 warehouse workers for 20 years. Over the follow-up period, 40 cadmium workers and 20 warehouse workers develop chronic kidney disease (proteinuria/nephropathy).
Construct the 2 × 2 contingency table.
Calculate cumulative incidence in exposed (Ie) and unexposed (Iu).
Calculate the Relative Risk (RR), Attributable Risk (AR), and Attributable Risk Percent (AR%).
Solution Steps:
Construct the 2 × 2 Table:
- Exposed (E+): a = 40 (diseased), b = 1,000 - 40 = 960 (non-diseased); Total = 1,000
- Unexposed (E-): c = 20 (diseased), d = 2,000 - 20 = 1,980 (non-diseased); Total = 2,000
Calculate cumulative incidence: I e = a a + b = 40 1 , 000 = 0.040 ( 4.0 % or 40 per 1 , 000 ) I_e = \frac{a}{a + b} = \frac{40}{1,000} = 0.040 \quad (4.0\% \text{ or } 40 \text{ per } 1,000) I e = a + b a = 1 , 000 40 = 0.040 ( 4.0% or 40 per 1 , 000 ) I u = c c + d = 20 2 , 000 = 0.010 ( 1.0 % or 10 per 1 , 000 ) I_u = \frac{c}{c + d} = \frac{20}{2,000} = 0.010 \quad (1.0\% \text{ or } 10 \text{ per } 1,000) I u = c + d c = 2 , 000 20 = 0.010 ( 1.0% or 10 per 1 , 000 )
Calculate measures of association:
Relative Risk (RR): R R = I e I u = 0.040 0.010 = 4.0 \mathbf{RR = \frac{I_e}{I_u} = \frac{0.040}{0.010} = 4.0} RR = I u I e = 0.010 0.040 = 4.0 (Cadmium-exposed workers have 4 times the risk of kidney disease compared to unexposed workers).
Attributable Risk (AR): A R = I e − I u = 0.040 − 0.010 = 0.030 ( 3.0 % or 30 excess cases per 1 , 000 ) \mathbf{AR = I_e - I_u = 0.040 - 0.010 = 0.030} \quad (3.0\% \text{ or } 30 \text{ excess cases per } 1,000) AR = I e − I u = 0.040 − 0.010 = 0.030 ( 3.0% or 30 excess cases per 1 , 000 )
Attributable Risk Percent (AR%): A R % = ( R R − 1 R R ) × 100 % = ( 4.0 − 1 4.0 ) × 100 % = 75.0 % \mathbf{AR\% = \left(\frac{RR - 1}{RR}\right) \times 100\% = \left(\frac{4.0 - 1}{4.0}\right) \times 100\% = \mathbf{75.0\%}} AR% = ( RR RR − 1 ) × 100% = ( 4.0 4.0 − 1 ) × 100% = 75.0% (75% of the kidney disease cases among electroplating workers are directly attributable to occupational cadmium exposure).
Worked Example 4.3.2: Odds Ratio Calculation in a Case-Control Study
Problem: A hospital-based case-control study evaluates occupational trichloroethylene (TCE) degreasing exposure and renal cell carcinoma. The study enrolls 150 confirmed renal cancer cases and 300 matched controls. Retrospective occupational hygiene exposure reconstruction reveals that 60 of the cases and 45 of the controls had significant past TCE degreaser exposure.
Construct the 2 × 2 table.
Calculate the Odds Ratio (OR).
State the epidemiological interpretation under the rare disease assumption.
Solution Steps:
Construct the 2 × 2 Table:
- Cases: a = 60 (exposed), c = 150 - 60 = 90 (unexposed); Total Cases = 150
- Controls: b = 45 (exposed), d = 300 - 45 = 255 (unexposed); Total Controls = 300
Calculate Odds Ratio (OR): O R = a ⋅ d b ⋅ c = 60 × 255 45 × 90 = 15 , 300 4 , 050 = 3.78 \mathbf{OR = \frac{a \cdot d}{b \cdot c} = \frac{60 \times 255}{45 \times 90} = \frac{15,300}{4,050} = \mathbf{3.78}} OR = b ⋅ c a ⋅ d = 45 × 90 60 × 255 = 4 , 050 15 , 300 = 3.78
Interpretation: The odds of prior occupational TCE exposure among renal cell carcinoma cases are 3.78 times higher than among healthy controls. Because renal cell carcinoma is a rare cancer in the general population, this Odds Ratio (OR = 3.78) serves as an accurate estimate of the Relative Risk (RR ≈ 3.78).